Low density lipoprotein cholesterol and coronary microvascular dysfunction in hypercholesterolemia

Journal of the American College of Cardiology

Volumn 36, Issue 1, 2000, Pages 103-109

  Kaufmann, Philipp A ^a,b   Gnecchi Ruscone, Tomaso ^a   Schäfers, Klaus P ^a   Lüscher, Thomas F ^b   Camici, Paolo G ^a  

^a IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; OXYGEN 15; TRIACYLGLYCEROL; WATER;

ADULT; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY DISEASE; CORONARY BLOOD VESSEL; ENDOTHELIUM; HEART MUSCLE BLOOD FLOW; HUMAN; HYPERCHOLESTEROLEMIA; MALE; MICROCIRCULATION; MICROVASCULATURE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REST;

ADENOSINE; BIOLOGICAL MARKERS; BLOOD FLOW VELOCITY; CHOLESTEROL, LDL; CORONARY CIRCULATION; CORONARY DISEASE; CORONARY VESSELS; HUMANS; HYPERCHOLESTEROLEMIA; INJECTIONS, INTRAVENOUS; MALE; MICROCIRCULATION; MIDDLE AGED; PROGNOSIS; TOMOGRAPHY, EMISSION-COMPUTED; VASODILATOR AGENTS;

EID: 0033911051     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(00)00697-5     Document Type: Article

References (74)

1. Zeiher A.M., Drexler H., Wollschlager H., Just H. Endothelial dysfunction of the coronary microvasculature is associated with impaired coronary blood flow regulation in patients with early atherosclerosis. Circulation. 84:1991;1484-1492.
2. Seiler C., Hess O.M., Buechi M., Suter T.M., Krayenbuehl H.P. Influence of serum cholesterol and other coronary risk factors on vasomotion of angiographically normal coronary arteries. Circulation. 88:1993;2139-2148.
3. Drexler H., Zeiher A.M., Meinzer K., Just J. Correction of endothelial dysfunction in coronary microcirculation of hypercholesterolaemic patients by L-arginine. Lancet. 338:1991;1546-1550.
4. Creager M.A., Gallagher S.J., Girerd X.J., Coleman S.M., Dzau V.J., Cooke J.P. L-Arginine improves endothelium-dependent vasolidation in hypercholesterolemic humans. J Clin Invest. 90:1992;1248-1253.
5. Leung W.H., Lau C.P., Wong C.K. Beneficial effect of cholesterol-lowering therapy on coronary endothelium-dependent coronary vasomotion in hypercholesterolemic patients. Lancet. 341:1993;1496-1500.
6. Egashira K., Hirooka Y., Kai H., et al. Reduction in serum cholesterol with pravastatin improves endothelium-dependent coronary vasomotion in patients with hypercholesterolemia. Circulation. 89:1994;2519-2524.
7. Treasure C.B., Klein J.L., Weintraub W.S., et al. Beneficial effects of cholesterol-lowering therapy on the coronary endothelium in patients with coronary artery disease. N Engl J Med. 332:1995;481-487.
8. Anderson T.J., Meredith I.T., Yeung A.C., Frei B., Selwyn A.P., Ganz P. The effect of cholesterol-lowering and antioxidant therapy on endothelium-dependent coronary vasomotion. N Engl J Med. 332:1995;488-493.
9. Kaufmann P.A., Frielingsdorf J., Mandinov L., Seiler C., Hug R., Hess O.M. Reversal of abnormal coronary vasomotion by calcium antagonists in patients with hypercholesterolemia. Circulation. 97:1998;1348-1354.
10. Dayanikli F., Grambow D., Muzik O., Mosca L., Rubenfire M., Schwaiger M. Early detection of abnormal coronary flow reserve in asymptomatic men at high risk for coronary artery disease using positron emission tomography. Circulation. 90:1994;808-817.
11. Yokoyama I., Ohtake T., Momomura S., Nishikawara J., Sasaki Y., Omata M. Reduced coronary flow reserve in hypercholesterolemic patients without overt coronary stenosis. Circulation. 94:1996;3232-3238.
12. Gould K.L., Martucci J.P., Goldberg D.I., et al. Short-term cholesterol lowering decreases size and severity of perfusion abnormalities by positron emission tomography after dipyridamole in patients with coronary artery disease. Circulation. 89:1994;1530-1538.
13. Czernin J., Barnard R.J., Sun K.T., et al. Effect of short-term cardiovascular conditioning and low-fat diet on myocardial blood flow and flow reserve. Circulation. 92:1995;197-204.
14. Guethlin M., Kasel A.M., Coppenrath K., Ziegler S., Delius W., Schwaiger M. Delayed response of myocardial flow reserve to lipid-lowering therapy with fluvastatin. Circulation. 99:1999;475-481.
15. Tanner F.C., Noll G., Boulanger C.M., Luscher T.F. Oxidized low density lipoproteins inhibit relaxations of porcine coronary arteries role of scavenger receptor and endothelium-derived nitric oxide . Circulation. 83:1991;2012-2020.
16. Hein W.H., Kuo L. LDLs impair vasomotor function of the coronary microcirculation role of superoxide anions . Circ Res. 83:1998;404-414.
17. Tamai O., Matsuoka H., Itabe H., Wada Y., Kohno K., Imamizumi T. Single LDL apheresis improves endothelium-dependent vasodilation in hypercholesterolemic humans. Circulation. 95:1997;76-82.
18. Shepherd J., Cobbe S.M., Ford I., et al. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. N Engl J Med. 333:1995;1301-1307.
19. Diamond G., Forrester J. Analysis of probability as an aid in the clinical diagnosis of coronary artery disease. N Engl J Med. 300:1979;1350-1358.
20. Hoffmann E.J., Phelps M.E., Huang S.C., Schelbert H.R. Dynamic, gated and high resolution imaging with the ECAT III. IEEE Trans Nucl Sci. 33:1986;452-455.
21. Spinks T.J., Jones T., Gilardi M.C., Heather J.D. Physical performance of the latest generation of commercial positron scanner. IEEE Trans Nucl Sci. 35:1988;721-725.
22. Uren N.G., Melin J.A., De Bruyne B., Wijns W., Baudhuin T., Camici P.G. Relation between myocardial blood flow and the severity of coronary artery stenosis. N Engl J Med. 330:1994;1782-1788.
23. Hermansen F., Rosen S.D., Fath-Ourdubadi F., et al. Measurement of myocardial blood flow with oxygen-15-labelled water comparison of different administration protocols . Eur J Nucl Med. 25:1998;751-759.
24. 15O blood pool scan. J Nucl Med. 39:1998;1696-1702.
25. Uren N.G., Crake T., Lefroy D.C., de Silva S.R., Davies G.J., Maseri A. Delayed recovery of coronary resistive vessel function after coronary angioplasty. J Am Coll Cardiol. 21:1993;612-621.
26. Kaufmann P.A., Gnecchi-Ruscone T., Yap J.T., Rimoldi O., Camici P.G., Lammertsma A.A. Assessment of the reproducibility of baseline and hyperemic myocardial blood flow measurements with oxygen-15-labeled water and PET. J Nucl Med. 40:1999;1848-1856.
27. Cerqueira M.D., Verani M.S., Schwaiger M., Heo J., Iskandrian A.S. Safety profile of adenosine stress perfusion imaging results from the Adenoscan Multicenter Trial Registry . J Am Coll Cardiol. 23:1994;384-389.
28. Andrews H.E., Bruckdorfer K.R., Dunn R.C., Jacobs M. Low-density lipoproteins inhibit endothelium-dependent relaxation in rabbit aorta. Nature. 327:1987;237-239.
29. Simon B.C., Cunningham L.D., Cohen R.A. Oxidized low density lipoproteins cause contraction and inhibit relaxation in the pig coronary artery. J Clin Invest. 86:1990;75-79.
30. Anderson T.J., Meredith I.T., Charbonneau F., et al. Endothelium-dependent coronary vasomotion relates to the susceptibility of LDL to oxidation in humans. Circulation. 93:1996;1647-1650.
31. Yokoyama I., Murakami T., Ohtake T., et al. Reduced coronary flow reserve in familial hypercholesterolemia. J Nucl Med. 37:1996;1937-1942.
32. Kavey R.E., Kveselis D.A., Gaum W.E. Exaggerated blood pressure response to exercise in children with increased low-density lipoprotein cholesterol. Am Heart J. 133:1997;162-168.
33. Pitkänen O., Nuutila P., Raitakari O.T., et al. Coronary flow reserve in young men with familial combined hyperlipidemia. Circulation. 99:1999;1678-1684.
34. Pajukanta P., Nuotio I., Terwilliger J.D., et al. Linkage of familial combined hyperlipidemia to chromosome 1q21-q23. Nat Genet. 18:1998;369-373.
35. Frielingsdorf J., Seiler C., Kaufmann P., Vassalli G., Suter T., Hess O.M. Normalization of abnormal coronary vasomotion by calcium antagonists in patients with hypertension. Circulation. 93:1996;1380-1387.
36. Gould K.L., Lipscomb K., Hamilton G.W. Physiologic basis for assessing critical coronary stenosis. Am J Cardiol. 33:1974;87-92.
37. de Silva R., Camici P.G. Role of positron emission tomography in the investigation of human coronary circulatory function. Cardiovasc Res. 28:1994;1595-1612.
38. Folkov B. 'Structural factor' in primary and secondary hypertension. Hypertension. 16:1990;89-101.
39. Larkin S.W., Clarke J.G., Keogh B.G., et al. Intracoronary endothelin induces myocardial ischemia by small vessel constriction in the dog. Am J Cardiol. 64:1989;956-958.
40. Clarke J.G., Davies G.J., Kerwin R., et al. Coronary artery infusion of neuropeptide Y in patients with angina pectoris. Lancet. 1:1987;1057-1059.
41. McFadden E.P., Clarke J.G., Davies G.J., Kaski J.C., Haider A.W., Maseri A. Effect of intracoronary serotonin on coronary vessels in patients with stable angina and patients with variant angina. N Engl J Med. 324:1991;648-654.
42. Chilian W.M., Layne S.M., Eastham C.L., Marcus M.L. Heterogeneous microvascular coronary α-adrenergic vasoconstriction. Circulation. 64:1989;376-388.
43. Nabel E.G., Ganz P., Gordon J.B., Alexander R.W., Selwyn A.P. Dilation of normal and constriction of atherosclerotic coronary arteries caused by the cold pressor test. Circulation. 77:1988;43-52.
44. Zeiher A.M., Drexler H., Wollschläger H., Saurbier B., Just H. Coronary vasomotion in response to sympathetic stimulation in humans importance of the functional integrity of the endothelium . J Am Coll Cardiol. 14:1989;1181-1190.
45. 1-adrenergic constriction limits coronary flow and cardiac function in running dogs. Am J Physiol. 250:1986;H1117-H1126.
46. Treasure C.B., Vita J.A., Cox D.A., et al. Endothelium-dependent dilation of the coronary microvasculature is impaired in dilated cardiomyopathy. Circulation. 81:1990;772-779.
47. Headrick J.P., Berne R.M. Endothelium-dependent and -independent relaxations to adenosine in guinea pig aorta. Am J Physiol. 259:1990;H62-H67.
48. Zanzinger J., Bassenge E. Coronary vasodilation to acetylcholine, adenosine and bradykinin in dogs effects of inhibition of NO-synthesis and captopril . Eur Heart J. 14:(Suppl 1):1993;164-168.
49. Smits P., Williams S.B., Lipson D.E., Banitt P., Rongen G.A., Creager M.A. Endothelial release of nitric oxide contributes to the vasodilator effect of adenosine in humans. Circulation. 92:1995;2135-2141.
50. Nees S. The adenosine hypothesis of metabolic regulation of coronary flow in the light of newly recognized properties of the coronary endothelium. Z Kardiol. 6:1989;42-49.
51. Leipert B., Becker B.F., Gerlach E. Different endothelial mechanisms involved in coronary responses to known vasodilators. Am J Physiol. 262:1992;H1676-H1683.
52. Mayhan W.G. Endothelium-dependent responses of cerebral arterioles to adenosine 5′ diphosphate. J Vasc Res. 29:1992;353-358.
53. Lupi A., Buffon A., Finocchiaro M.L., Conti E., Maseri A., Crea F. Mechanisms of adenosine-induced epicardial coronary artery dilatation. Eur Heart J. 18:1997;614-617.
54. Dart A.M., Chin-Dusting J.P. Lipids and the endothelium. Cardiovasc Res. 43:1999;308-322.
55. Nitenberg A., Valensi P., Sachs R., Dali M., Aptecar E., Attali J.R. Impairment of coronary vascular reserve and ACh-induced coronary vasodilation in diabetic patients with angiographically normal coronary arteries and normal left ventricular systolic function. Diabetes. 42:1993;1017-1025.
56. Zeiher A.M., Schachinger V., Minners J. Long-term cigarette smoking impairs endothelium-dependent coronary arterial vasodilator function. Circulation. 92:1995;1094-1100.
57. Kugiyama K., Kerns S.A., Morrisett J.D., Roberts R., Henry P.D. Impairment of endothelium-dependent relaxation by lysolecithin in modified low-density lipoproteins. Nature. 344:1990;160-162.
58. Ohara Y., Peterson T.E., Harrison D.G. Hypercholesterolemia increases endothelial superoxide anion production. J Clin Invest. 91:1993;2546-2551.
59. Pritchard K.A., Groszek L., Smalley D.M., et al. Native low-density lipoprotein increases endothelial cell nitric oxide synthase generation of superoxide anion. Circ Res. 77:1995;510-518.
60. Rubanyi G.M., Vanhoutte P.M. Oxygen-derived free radicals, endothelium and responsiveness of vascular smooth muscle. Am J Physiol. 250:1986;H815-H821.
61. Ohara Y., Peterson T.E., Sayegh H.S., Subramanian R.R., Wilcox J.N., Harrison D.G. Dietary correction of hypercholesterolemia in the rabbit normalizes endothelial superoxide anion production. Circulation. 92:1995;898-903.
62. Stewart-Lee AL, Forster LA, Nourooz-Zadeh J, Ferns GAA, Ängård EE. Vitamin E protects against impairment of endothelium-mediated relaxations in cholesterol-fed rabbits. Atherioscler Thromb 1994;14:494-9.
63. Keany J.F., Xu A., Cunningham D., Jackson T., Frei B., Vita J.A. Dietary probucol preserves endothelial function in cholesterol-fed rabbits by limiting vascular oxidative stress and superoxide generation. J Clin Invest. 95:1995;2520-2529.
64. Mügge A., Elwell J.H., Peterson T.E., Hofmeyer T.G., Hestad D.D., Harrison D.G. Chronic treatment with polyethylene glycolated superoxide dismutase partially restores endothelium-dependent vascular relaxation in cholesterol-fed rabbits. Circ Res. 69:1991;1293-1300.
65. Steinberg D., Parthasarathy S., Carew T.E., Khoo J.C., Witztum J.L. Beyond cholesterol modification of low-density lipoprotein that increases its atherogenicity . N Engl J Med. 320:1989;915-924.
66. Murohara T., Kugiyama K., Ohgushi M., Sugiyama S., Ohta Y., Yasue H. LPC in oxidized LDL elicits vasoconstriction and inhibits endothelium-dependent relaxation. Am J Physiol. 297:1994;H2441-H2449.
67. Mangin E.L., Kugiyama K., Nghuy J.H., Kerns S.A., Henry P.D. Effects of lysolipids and oxidatively modified low density lipoprotein on endothelium-dependent relaxation of rabbit aorta. Circ Res. 72:1993;161-166.
68. Shimokawa H., Flavahan N.A., Vanhoutte P.M. Loss of endothelial pertussis toxin-sensitive G protein function in atherosclerotic porcine coronary arteries. Circulation. 83:1991;652-660.
69. Chin J.H., Azhar S., Hoffman B.B. Inactivation of endothelial derived relaxing factor by oxidized lipoproteins. J Clin Invest. 89:1992;10-18.
70. Lerman A., Edwards B.S., Hallett J.W., Heublein D.M., Sandberg S.M., Burnett J.C. Circulating and tissue endothelin immunoreactivity in advanced atherosclerosis. N Engl J Med. 325:1991;997-1001.
71. Lerman A., Holmes D.R., Bell M.R., Garratt K.N., Nishimura R.A., Burnett J.C. Endothelin in coronary endothelial dysfunction and early atherosclerosis in humans. Circulation. 92:1995;2426-2431.
72. Shepherd J. A call to action. Eur Heart J. 19:(Suppl M):1998;M2-M7.
73. Durrington P.N., Prais H., Bhatnagar D., et al. Indications for cholesterol-lowering medication comparison of risk-assessment methods . Lancet. 353:1999;278-281.
74. Grover S. Gambling with cardiovascular risk picking the winners and the losers . Lancet. 353:1999;254-255.